 |
Indication & Dosage |
| |
| |
| Oral |
| HYPERPHOSPHATAEMIA IN END STAGE RENAL FAILURE |
| Adult:
Initially, 0.75-2.25 g daily, given in divided doses wth meals. Dose may be adjusted every 2-3 wk until an acceptable serum phosphate concentration is achieved; usual maintenance dose: 1.5-3 g daily in divided doses. Max: 3.75 g daily. |
|
| |
|
| Administration |
Should be taken with food. (Take w/ or immediately after meals. Chew thoroughly before swallowing. Do not swallow whole.) |
| |
|
| Precautions |
Caution when used in patients with acute peptic ulcer, ulcerative colitis, Crohn's disease or bowel obstruction. Tablets should be thoroughly chewed before swallowing. Pregnancy and lactation. |
| |
|
| Adverse Drug Reactions |
GI disturbances, including nausea, vomiting, constipation, diarrhoea, dyspepsia and abdominal pain. |
| |
|
| Interactions |
Compounds that are known to interact with antacids should not be taken within 2 hr of administering lanthanum carbonate. |
| |
|
|
|
